Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Izotropic Corporation (IZOZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4800+0.0500 (+11.63%)
At close: 02:34PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Newsfile

    Izotropic Unveils Izoview Commercial Prototype, Files New Patents

    Vancouver, British Columbia--(Newsfile Corp. - May 10, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to unveil the commercial prototype device design that will be used in forthcoming clinical studies for market authorization in the U.S.To view an enhanced version of this gr

  • Newsfile

    Izotropic Corporation Announces Closing of Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - April 4, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to announce, further to its news release on March 30, 2022, that it has completed a non-brokered private placement (the "Offering") of unsecured promissory notes (each, a "

  • Newsfile

    Breast CT Authority and Head of Clinical Trials Joins Izotropic

    Vancouver, British Columbia--(Newsfile Corp. - March 14, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to announce the addition of Dr. Shadi Aminololama- Shakeri, MD, FSBI to its advisory board and commercialization team as a clinical consultant. Dr. Shakeri is the Chief of

Advertisement
Advertisement